Cofirasersen sodium is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.
Molecular Weight:
5789.18
Formula:
C172H202N57Na16O88P15S15
Target:
Sodium Channel
Application Notes:
Oligonucleotides
* VAT and and shipping costs not included. Errors and price changes excepted
